American Portfolios Advisors’s Juno Therapeutics, Inc. JUNO Stock Holding History

American Portfolios Advisors’s Portfolio JUNO Stock Details JUNO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-135	Closed	-$6.17K	–	2440
2017 Q4	$6.17K	Buy	+135	New	+$6.73K	﹤0.01%	1755

Other funds holding JUNO

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Glenmede Trust Philadelphia, Pennsylvania $22.7B AUM

American Portfolios Advisors's JUNO Position: Q1 2018 in Review

American Portfolios Advisors sold out of Juno Therapeutics, Inc. (JUNO) in Q1 2018, closing a stake of 135 shares — an estimated $6.17K sold.

American Portfolios Advisors first reported a position in JUNO in Q4 2017 and held it in 1 quarter. The position peaked at $6.17K in Q4 2017. 2 funds tracked by Wall St. Rank hold JUNO as of Q1 2018.

American Portfolios Advisors reported no remaining Juno Therapeutics, Inc. position as of Q1 2018 after selling out during the quarter.
American Portfolios Advisors sold 135 Juno Therapeutics, Inc. shares in Q1 2018, an estimated $6.17K.
American Portfolios Advisors first reported a position in Juno Therapeutics, Inc. in Q4 2017 and held it in 1 quarter.
American Portfolios Advisors's Juno Therapeutics, Inc. position peaked at $6.17K in Q4 2017.
2 funds tracked by Wall St. Rank held Juno Therapeutics, Inc. as of Q1 2018.

Based on American Portfolios Advisors's 13F filing for Q1 2018, filed 24 Mar 2023.